Mednet Logo
HomeQuestion

What brachial plexus dose constraints do you apply when treating conventionally fractionated NSCLC?

3 Answers
Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

Yes. I am presuming you are discussing treating definitively with CRT for locally advanced NSCLC.

Since RTOG 0617, most people that treat NSCLC prescribe to a dose of 60-66 Gy in 30-33 fx, as this is a feared toxicity that is very painful and decreases QOL. We try to keep the brachial plexus dose to ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology

Agreed with Dr. @Dr. First Last. Of note, if you are treating a superior sulcus tumor near the brachial plexus, you might consider the Intergroup 0160 regimen of pre-op chemoRT followed by surgery. In this trial, they used a dose of 45 Gy/25# with cisplatin/etoposide, but one could go higher to a de...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Kona Community Hospital

NCCN lists median brachial plexus dose constraint as < 69Gy for conventionally fractionated 30-35Fx regimen. (When I inquired a while back, they confirmed this wasn't a typo).

Register or Sign In to see full answer

What brachial plexus dose constraints do you apply when treating conventionally fractionated NSCLC? | Mednet